LANZA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 9.652
EU - Europa 3.107
AS - Asia 1.693
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
SA - Sud America 3
Totale 14.476
Nazione #
US - Stati Uniti d'America 9.639
PL - Polonia 1.069
CN - Cina 826
IT - Italia 549
UA - Ucraina 534
DE - Germania 339
SG - Singapore 326
TR - Turchia 267
GB - Regno Unito 249
FI - Finlandia 129
VN - Vietnam 115
SE - Svezia 111
ID - Indonesia 82
FR - Francia 49
HK - Hong Kong 21
BE - Belgio 18
RU - Federazione Russa 15
IN - India 14
JP - Giappone 14
CA - Canada 13
CZ - Repubblica Ceca 13
ES - Italia 12
AU - Australia 7
TW - Taiwan 6
IR - Iran 5
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AT - Austria 3
BG - Bulgaria 3
MD - Moldavia 3
NL - Olanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BR - Brasile 2
DZ - Algeria 2
GR - Grecia 2
IE - Irlanda 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
IQ - Iraq 1
KR - Corea 1
LK - Sri Lanka 1
NO - Norvegia 1
Totale 14.476
Città #
Fairfield 1.508
Woodbridge 1.119
Warsaw 1.066
Houston 931
Ashburn 638
Jacksonville 622
Wilmington 617
Seattle 563
Chandler 537
Ann Arbor 517
Cambridge 487
Princeton 312
Izmir 186
Nanjing 186
Singapore 184
Beijing 172
Milan 166
San Diego 156
Dong Ket 115
Jakarta 81
Boardman 77
Nanchang 61
Shanghai 58
Shenyang 57
Falls Church 50
New York 46
Redwood City 45
Bremen 44
Hebei 39
London 39
Ferrara 36
Norwalk 35
Changsha 33
Jiaxing 33
Mountain View 31
Tianjin 25
Dearborn 22
Hong Kong 21
Kunming 20
Los Angeles 20
Rome 20
Jinan 19
Zhengzhou 17
Brussels 16
San Mateo 16
Chicago 15
Ningbo 14
Addison 13
Guangzhou 13
Helsinki 13
Redmond 11
Faenza 10
Orange 10
Taizhou 10
Washington 10
Wuhan 10
Auburn Hills 9
Brno 9
Lanzhou 9
Hounslow 8
Kilburn 8
Parma 8
Bologna 7
Chiswick 7
Des Moines 7
Düsseldorf 7
Hamilton 7
Verona 7
Haikou 6
Naples 6
Saint Louis 6
Augusta 5
Florence 5
Mestre 5
Munich 5
Siena 5
Tokyo 5
Acton 4
Barcelona 4
Genoa 4
Hangzhou 4
Monmouth Junction 4
Parabiago 4
Philadelphia 4
Springfield 4
Tappahannock 4
Arcadia 3
Auckland 3
Bangalore 3
Casapesenna 3
Chisinau 3
Forest City 3
Indiana 3
Messina 3
Monselice 3
Nazareth 3
New Taipei 3
Padova 3
Prescot 3
Santa Maria Di Sala 3
Totale 11.391
Nome #
Predictive value of hematological and phenotypical parameters on postchemotherapy leukocyte recovery 194
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 188
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 185
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 165
PCR con primer degenerati non evidenza sequenze virali di HHV8 nè di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 152
Identification of Chlamydia trachomatis in a patient with ocular lymphoma 146
null 142
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 140
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 138
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 134
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 131
New monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 127
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 125
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 125
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 123
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 123
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 119
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 118
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 118
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 117
CD34+ cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation 114
RABBIT IgG ANTIBODIES AGAINST CORD RED BLOOD CELL MEMBRANES BIND TO COMPLEMENT RECEPTOR 1 (CD35) 113
Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical-biological features. 111
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 110
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 107
Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia 107
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 104
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 103
CXCR-4 Expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies 102
CD34+CD33+ blast cells: Correlation with FAB subtypes 100
Immunosuppressive properties of mesenchymal stromal cells 100
A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach 99
CD34 quantitative flow cytometry study of the blastic population in acute leukemias. 98
BCR-ABL rearrangement is not detectable in essential thrombocythemia 96
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics 96
Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts 94
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 93
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis. 91
CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review 90
PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients 88
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia 88
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 87
Autologous stem cell transplantation: is it still relevant in breast cancer? 85
null 85
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 84
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. 82
Studio dei progenitori emopoietici circolanti in pazienti con infarto del miocardio 82
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 79
Isolamento e caratterizzazione immunofenotipica di cellule non-emopoietiche presenti in versamenti ascitici e pleurici di pazienti con malattie ematologiche 79
Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy? 77
Assessment of growth of endothelial cells and fibroblasts in long-term cultures of patients with haematological malignancies. 77
null 77
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen 76
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia 75
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 75
Bone marrow stromal cells in acute promyelocytic leukaemia: comparison with other acute myelogenous leukaemia subtypes. 74
Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT) 73
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation 73
Differences among young adults, adults and elderly chronic myeloid leukemia patients 73
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database 72
Adverse haematological effects of ticlopidine. A report of four cases 71
null 71
Assessment of bone marrow-derived endothelial cells in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation 71
Citometria a flusso: applicazioni in ematologia 71
Post-thaw viability of cryopreserved peripheral blood stem cells: what are we actually looking at? 71
Absence of HTLV-1 in myelodysplastic syndromes in an area non endemic for HTLV-1 infection. 68
Move on air: Webinar for education in stem cells mobilization Report I 68
High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry 67
Photomultiplier voltage setting: Possible important source of variability in molecular equivalents of soluble fluorochrome (MESF) calculation? 66
Novel Applications for the Flow Cytometry 66
p53 exon 5 mutation in two cases of leukemic mantle cell lymphoma 65
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study 65
In vitro expansion and immunophenotypic characterization of circulating stem celle in patients affected by systemic scleoris (SSc): possible implications in fibrosis process 64
Sources and procurements of HSC 64
Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: A 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT) 64
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 63
Chlamydia trachomatis and Ocular Lynphoma. a possible link? 62
Human bone marrow endothelial-colony growth before and after stem cell transplantation in non-hodgkin’s lymphoma patients. 62
Is allogeneic transplant for solid tumors still alive? 62
Hematopoietic SCT in Europe 2013: Recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants 62
null 61
Long term cultured bone marrow cell from multiple myloma patients give rise to higher number of endothelial colonies than MGUS patients and normal controls 61
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 61
Trapianto autologo di cellule staminali in paziente affetta da sclerosi sistemica a varietà diffusa. 60
Correlation between doses of CD34+ cell subsets infused, number of long-term culture colony forming cells and kinetics of engrafment in patients receiving autologous peripheral blood stem cell transplant 60
Eterogeneita’ immunofenotipica di cellule staminali mesenchimali dopo espansione ex vivo 60
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 60
Multicolor analysis of bone marrow stromal cells from normal and leukemic patients 59
Cellule mesenchimali stromali: caratterizzazione immunofenotipica e funzionale 59
Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually 59
Cytofluorimetric analysis of cytokine receptors in blast cells from acute leukemia. 58
Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report 58
Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma 58
Production of solubile HLA-G antigens by bone marrow - derived human mesenchimal cells (B-MSCS) has a role in the inhibition of the lymphoproliferative response. 57
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 57
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model 57
Production of soluble HLA-G antigens is involved in the inhibition of lymphoproliferative response by human mesenchymal stromal cells (MSC) from different sources 55
Development of adaptive immune effector therapies in solid tumors 55
Production of soluble HLA-G molecules by mesenchymal stromal cells after in vitro IL-10 activation: a marker for “a priori” evaluation of their immunoregulatory activity 54
Functional and immunophenotypic characteristics of isolated CD105+ and fibroblasts+ mesenchymal cells from acute myeloid leukaemia: implication for their plasticity along endothelial lineage 54
Totale 8.885
Categoria #
all - tutte 90.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.160
Totale 93.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.409 0 44 40 227 89 216 118 183 583 482 278 149
2020/20214.512 332 356 315 315 361 521 180 437 112 722 666 195
2021/20222.419 198 348 74 131 75 80 123 169 110 284 151 676
2022/20231.650 306 54 71 265 216 207 55 144 177 21 84 50
2023/2024868 87 89 61 35 52 67 25 50 27 18 34 323
2024/2025206 159 47 0 0 0 0 0 0 0 0 0 0
Totale 15.166